Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo... on 24 February 2026 at 8h54
Vitamin A Deficiency: Symptoms, Causes, and Prevention of Blindness Vitamin A deficiency remains a significant global health concern, often leading to severe vision problems and, in extreme cases, blindness. Recognizing... on 24 February 2026 at 7h55
LawFairy Marks a First as a Deterministic, Technology-Only Law Firm LONDON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- LawFairy has received authorisation from the Solicitors Regulation Authority (SRA) to operate as... on 24 February 2026 at 7h53
Yasam Ayavefe Provides Further Update on Structured Review of Potential Black Penny Dubai Expansion Yasam Ayavefe confirms the structured evaluation of The Black Penny’s potential Dubai expansion has advanced into a detailed commercial... on 24 February 2026 at 6h52
Lerøy Seafood Group ASA: Q4 2025 Results LERØY SEAFOOD GROUP ASA: SOLID OPERATIONS AND GOOD BIOLOGICAL PERFORMANCE IN THE FOURTH QUARTER «Operational EBIT in the fourth quarter... on 24 February 2026 at 5h51
Neutys Launches AI-Driven Web3 Intelligence Ecosystem for Decentralized Market Analytics BERTRANGE, Luxemburg , Feb. 23, 2026 (GLOBE NEWSWIRE) -- Neutys today announced the official launch of its AI-Driven Web3 Intelligence Ecosystem,... on 24 February 2026 at 2h48
Treefera Market Insights Now Available in Smartkarma LONDON , Feb. 23, 2026 (GLOBE NEWSWIRE) -- Treefera, the AI-native first-mile intelligence platform for ag & soft commodities, today announced... on 24 February 2026 at 0h46